The triazine herbicides, atrazine (ATR), simazine (SIM), propazine (PRO), terbuthylazine (TBA), and their chlorinated metabolites have been implicated in the etiology of testicular dysgenesis by altering steroidogenesis. To further investigate their effects on testosterone biosynthesis, BLTK1 cells were used to evaluate steroid hormone levels and genome-wide gene expression. BLTK1 cells are a novel murine Leydig cell line possessing an intact steroidogenic pathway with constitutive low basal testosterone (T) levels that can be induced by recombinant human chorionic gonadotropin (rhCG). Triazines (ATR, SIM, PRO, and TBA) and their chlorometabolites (DEA, DIA, and DACT) induced concentration-dependent (1, 3, 10, 30, 100, 300, and 600 µM) increases in progesterone (P) and T levels relative to solvent control at 24 h. Temporal analysis (300 µM at 1, 2, 4, 8, 12, 24, or 48 h) elicited comparable P and T profiles by all compounds with varying efficacies (ATR > TBA > PRO > DEA > DIA > DACT >> SIM) that were similar to rhCG. ATR and TBA elicited time-and concentration-dependent induction of Star, Hsd3b6, and Hsd17b3 mRNA levels, whereas Hsd3b1, Cyp17a1, and Srd5a1 mRNA expression was repressed. PRO elicited similar albeit weaker effects, whereas SIM had negligible effects consistent with their induction of P and T levels. Whole-genome microarrays identified 797 differentially regulated genes elicited by 300 µM ATR, occurring primarily at later time points (> 12 h) with overrepresented functions associated with steroidogenesis and cholesterol metabolism. These results indicate that changes in P and T levels can be partially attributed to triazine-elicited alterations in steroidogenic gene expression.
hypothalamic-pituitary-gonadal (HPG) axis (USEPA, 2002 (USEPA, , 2006d . CMGs are defined for cumulative risk assessment as two or more chemicals that cause a common toxic effect(s) using the same sequence of major biochemical events, interpreted as mode of action (USEPA, 2012a). Moreover, their major chlorometabolites are classified as toxicologically equipotent to the parent triazines by the CMG (USEPA, 2006d) . Therefore, all triazines and their major chlorometabolites require further examination regarding potential endocrine-disrupting activities.
The endocrine-disrupting effects of triazines and their chlorometabolites have been extensively studied in mammalian models and aquatic species. In amphibians, reptiles, and fish, ATR reduced reproductive capacity, disrupted steroidogenesis, and altered gonadal development resulting in hermaphroditism and male feminization (Crain et al., 1997; Hayes et al., 2002 Hayes et al., , 2010 Spanò et al., 2004; Tillitt et al., 2010) . Effects on steroidogenesis in amphibians and fish suggest that disruption of testosterone (T) biosynthesis may underlie the effects of ATR in males (Hayes et al., 2002 (Hayes et al., , 2010 Sanderson, 2006) . Rodent studies also report that ATR disrupts male and female reproductive tract development and function by altering steroid levels that affect estrus, androgen-dependent tissue development, puberty onset, reproductive senescence, and overall fertility (Cooper et al., 2007; Laws et al., 2000; Narotsky et al., 2001; Stoker et al., 2000) . PRO, SIM, DEA, DIA, and DACT elicit similar effects in rodents that are generally characterized as ATR-like with a limited number of studies examining TBA Laws et al., 2003; Stoker et al., 2002; Zorrilla et al., 2010) . Collectively, these results suggest that triazines and their chlorometabolites target the HPG axis (Cooper et al., 2007; Laws et al., 2009) .
This study examines the effects of ATR, SIM, PRO, TBA, and their primary chlorometabolites (DEA, DIA, and DACT) on steroidogenesis in BLTK1 murine Leydig cells. Leydig cells are the primary site for T biosynthesis required for proper male development and reproduction. Briefly, luteinizing hormone (LH) stimulation induces the expression and activation of steroidogenic enzymes, which increases progesterone (P) levels and metabolism to T (Dufau et al., 1984; Payne and Youngblood, 1995) . BLTK1 cells, a subclone of a murine Leydig cell line isolated from a testicular tumor in a inhibin α/SV40Tag transgenic mouse, produce low basal P and T levels (Forgacs et al., 2012; Rahman and Huhtaniemi, 2004) . Unlike other murine Leydig cell lines such as BLTC-1 (Kananen et al., 1996) , MA-10 (Ascoli, 1981) , and mLTC-1 (Rebois, 1982) , which do not proceed beyond P biosynthesis, BLTK1 cells produce appreciable basal levels of T, which can be induced by rhCG, an LH analog (Forgacs et al., 2012) . In this study, we have evaluated the time-and concentrationdependent effects of ATR, SIM, PRO, TBA, and their major chlorometabolites on P and T production and gene expression in BLTK1 cells. Our results confirm that changes in P and T levels can be partially attributed to triazine-elicited alterations in steroidogenic gene expression.
MATERIALS AND METhODS
Cell culture and treatment. BLTK1 cells were maintained in phenol redfree Dulbecco's modified Eagle's medium nutrient mixture F-12 (DMEM/F-12 media; Invitrogen, Carlsbad, CA) with 10% fetal bovine serum (FBS; Thermo Scientific HyClone, Logan, UT), 100 U/ml penicillin, and 100 μg/ ml streptomycin (Invitrogen) and incubated under standard conditions (5% CO 2 , 37°C). Cells were seeded at 80% confluency in 24-well tissue culture plates (Sarstedt, Newton, NC) for measurement of P and T levels in media. Concentration-response studies at 24 h were conducted with dimethyl sulfoxide (DMSO; vehicle; Sigma, St Louis, MO); 0.1, 0.3, 1, 3, 10, 30, or 100 ng/ ml rhCG (obtained from A.F. Parlow, NIDDK's National Hormone & Peptide Program, Harbor-UCLA Medical Center, Torrance, CA); or 1, 3, 10, 30, 100, 300, or 600 μM of ATR (Sigma), DIA, DEA, DACT, PRO, SIM, or TBA (Accustandard, New Haven, CT). Time course studies were conducted with DMSO (vehicle), 300 μM ATR, DIA, DEA, DACT, PRO, SIM, or TBA, and rhCG (3 ng/ml) as a positive control. The entire volume of media from wells was collected at 1, 2, 4, 8, 12, 24, or 48 h, with different wells used for each time point, such that cumulative steroid production was evaluated for the time points indicated. Cells were grown to 80% confluency in T-25 flasks (Sarstedt) for RNA isolation.
MTT cytotoxicity assay. BLTK1 cells, plated into 96-well tissue culture plates (Starstedt), were treated with 1, 3, 10, 30, 100, 300, or 600 ng/ml rhCG or 1, 3, 10, 30, 100, 300, or 600 μM of ATR, PRO, SIM, TBA, DEA, DIA, or DACT. After 24 h, media were aspirated and 50 μl of freshly prepared MTT reagent (5 mg/ml thiazolyl blue tetrazolium bromide (Sigma) in PBS) was added to each well. Cells were incubated for 3 h, and then MTT reagent was aspirated and 150 μl DMSO was added to each well for 2 h before spectrophotometric measurement of product at 595 and 650 nm (A595-A650) using an Emax precision microplate reader (Molecular Devices, Sunnyvale, CA). Results are reported as percentage of control calculated from relative absorbance of treated versus controls, where 100% indicates no cytotoxicity. MTT assay results are presented in Supplementary figure S1.
Enzyme immunoassays. T (Cayman Chemical Company, Ann Arbor, MI) and P (ALPCO Diagnostics, Salem, NH) enzyme immunoassay (EIA) kits were used following manufacturer's instructions, as previously described (Forgacs et al., 2012) . Briefly, conjugated hormone and sample compete for antibody on 96-well precoated plates. Following incubation, the plates were washed, and a reaction was initiated to yield a spectrophotometrically detectable product (412 nm for T, 450 nm for P) using an Emax precision microplate reader (Molecular Devices). A standard curve (3.9-500 pg/ml T and 0-60 ng/ ml P) was generated for P and T quantification. All chemicals were confirmed to have no cross-reactivity with the EIA kits (data not shown).
RNA isolation and quantitative real-time PCR. Treated cells (T-25 flasks) were trypsinized (Invitrogen) and stored as pellets at −80°C. RNA was extracted using RNeasy Mini Kits (QIAGEN, Valencia, CA) according to the manufacturer's protocol with an additional RNase-free DNase (QIAGEN) digestion. RNA was spectrophotometrically quantified at 260 nm (A260), and purity was assessed using the A260/A280 ratio and denaturing gel electrophoresis.
RNA (1 µg) was reverse transcribed by SuperScript II (Invitrogen) using an anchored oligo-dT primer (Invitrogen) as described by the manufacturer. Quantitative real-time PCR (QRTPCR) reactions consisted of 30 µl reaction volumes that included 1 µl of cDNA template, 0.1 µM forward and reverse gene-specific primers, 3 mM MgCl 2 , 1 mM dNTPs, 0.025 IU AmpliTaq Gold, and 1× SYBR Green PCR Buffer (Applied Biosystems, Foster City, CA) were carried out in 96-well plates and amplified using an Applied Biosystems PRISM 7500 Sequence Detection System. Dissociation curve analysis assessed single product amplification. To control for differences in RNA loading, quality, and cDNA synthesis, samples were standardized to the geometric mean of three housekeeping genes (Actb, Gapdh, and Hprt) (Vandesompele et al., 2002) . Primer sequences for all genes evaluated are available in Supplementary table 1. Results were quantified using a standard curve generated on the same 96-well plate used for samples by amplifying a purified cDNA template specific for each gene (serial 10× dilutions from 10 8 to 10 1 copies). Standard curve slope was used to assess amplification efficiency, as described by the manufacturer, with all amplification efficiencies between 80 and 100%. Fold changes were calculated relative to time-matched vehicle. Relative expression levels were scaled such that the expression level of the time-matched vehicle control group equaled one for graphing purposes.
Microarray analysis. The temporal changes in gene expression elicited by 300 μM ATR were evaluated using Agilent mouse 4 × 44K oligonucleotide microarrays according to the manufacturer's protocol (Agilent Manual: G4140-90050 v5.0.1; array product number: G4122F; Agilent Technologies, Santa Clara, CA). Briefly, 1 μg total RNA from ATR-treated BLTK1 cells and time-matched DMSO controls was labeled independently with Cy3 and Cy5 dye and cohybridized in an independent reference design. This design involves comparing treated samples to controls with two independent labelings per sample (dye swap) for a total of 14 arrays per replicate (seven time points with dye swap). Three replicates of this design were performed for a total of 42 arrays. Microarrays were scanned at 532 nm (Cy3) and 635 nm (Cy5) using a GenePix 4000B scanner (Molecular Devices, Union City, CA), using GenePix Pro 6.0 to extract features and background intensities. All images and data were loaded into the TIMS dbZach data management system (Burgoon and Zacharewski, 2007) . All microarray data passed our quality assurance protocols and were normalized in SAS v9.1 (SAS Institute, Cary, NC) using a semiparametric approach . Posterior probabilities were determined on a per gene and per time point basis (Eckel et al., 2004) to determine model-based t-values (SAS v9.1), which were then used to determine P1(t) values by an empirical Bayes method using R (R, Institute for Statistics and Mathematics, WU Wien). Data were filtered and prioritized in a MySQL v5.1.40 database using a filtering criteria of |fold change| > 1.5 and P1(t) > 0.999 to identify differentially expressed genes. The complete microarray data set including fold change and P1(t) values is available in Supplementary table 2.
Functional annotation was carried out using Ingenuity Pathway Analysis (IPA, Ingenuity Systems, Redwood City, CA; www.ingenuity.com) and the Database for Annotation, Visualization and Integrated Discovery (DAVID; http://david.abcc.ncifcrf.gov/). Using IPA, genes were evaluated on a per time point basis to identify significantly enriched (p value < 0.05) functions. The IPA transcription factor tool was used to identify predicted activation or inhibition of transcription factors. K-means clustering was conducted using the TM4 MultiExperiment Viewer v.4.6.0 (Saeed et al., 2003) . DAVID was used to identify significantly enriched (p value < 0.05) Gene Ontology (GO) biological process functional annotation terms (GOTERM_BP_FAT).
Statistical analyses and dose-response modeling. EIA and QRTPCR concentration-response data were analyzed using SAS v9.1 (SAS Institute) by ANOVA followed by Dunnett's post hoc test. Differences between groups were considered significant when p < 0.05. EIA and QRTPCR data from time course studies were also analyzed by SAS v9.1 by ANOVA, but followed by Tukey's post hoc test, using a significance cutoff of p < 0.05. Dose-response modeling was carried out using a particle swarm optimization algorithm (ToxResponse modeler (Burgoon and Zacharewski, 2008) ) to identify the best fit across five model classes (sigmoidal, exponential, linear, quadratic, and Gaussian). All EC 50 values included in this study were determined from sigmoidal concentration-response curves.
RESuLTS

Effect of Triazines and Their Chlorometabolites on P and T Levels
The effect of triazine herbicides and their primary chlorometabolites on P and T levels in media was assessed by EIA at 24 h. ATR, PRO, SIM, or TBA and DEA, DIA, and DACT elicited concentration-dependent increases in P levels at 24 h albeit with lower efficacy and potency relative to rhCG (Fig. 2) . Each triazine and chlorometabolite induced P at 100-600 μM, with a maximum induction of ~3.5-fold (90 ng/ml) in response to 600 μM ATR relative to vehicle controls. In comparison, P levels were induced up to 170 ng/ml (~sixfold) following treatment with 100 ng/ml rhCG. The EC 50 for P induction by rhCG was 0.8 ng/ml, whereas triazine and chlorometabolite EC 50 s were ~33 μM. Differences in efficacy were more evident for T, where 100 ng/ml rhCG induced levels ~fourfold (170 pg/ml) and ATR only elicited a ~twofold (75 pg/ml) increase. SIM was the least efficacious with a modest 1.3-fold induction of T. EC 50 values for T induction were 0.7 ng/ml for rhCG and 30-45 μM for the triazines and chlorometabolies. DACT only had T induction at 600 μM, and therefore, an EC 50 value could not be determined using the ToxResponse modeler. Overall, each compound elicited concentration-dependent induction of P and T levels, with ATR exhibiting the greatest efficacy.
Based on the 24-h concentration-response analysis, 300 μM was used to examine the time-dependent effects of the parent triazines and their primary chlorometabolites on the induction of P and T levels. ATR, TBA, and PRO elicited comparable temporal P and T profiles albeit with lower potency compared with rhCG ( Fig. 3) with efficacy similar to levels in the concentration-response studies. Like rhCG, triazines and their chlorometabolites induced maximum P levels by 2 h, which subsequently decreased, whereas rhCG maintained P levels for 2-4 h before decreasing. Concomitantly, T increases were inversely proportional to the time-dependent decreases in P levels. However, rhCG-mediated efficacy was significantly greater than the levels induced by any triazine or chlorometabolite. Although SIM and DACT elicited comparable temporal profiles, the effects on P and T levels were not statistically significant (Supplementary table 4) . Overall, ATR, SIM, PRO, TBA, DEA, DIA, and DACT elicited comparable temporal effects on P and T levels with differences in efficacy.
Triazine Effects on Steroidogenic Enzyme Gene Expression Profiles
The expression of steroidogenic enzymes involved in the metabolism of cholesterol to progestagens, androgens, and estrogens was evaluated by QRTPCR for parent triazines and rhCG. ATR, PRO, and TBA elicited concentration-dependent differential expression of several steroidogenic genes at 24 h (Fig. 4) . Compared with the ~20-fold rhCG-mediated induction of Star, only ATR, PRO, and TBA induced Star mRNA levels (4-, 3-, and 3.5-fold, respectively), whereas SIM had negligible effects. Meanwhile, Hsd3b6 mRNA induction was comparable (~threefold) for ATR, PRO, and TBA, similar to rhCG. Interestingly, Hsd3b1 was repressed 10-, 10-, and 4-fold in response to 600 μM ATR, TBA, and PRO, respectively, whereas rhCG had no significant effect on the expression of this gene. Although Cyp17a1 was also repressed (eight-, seven-, and fourfold decrease by ATR, PRO, and TBA, respectively), rhCG and SIM elicited negligible effects. Srd5a1 was induced ~threefold by rhCG but repressed ~twofold by ATR, PRO, and TBA. Hsd17b3 mRNA levels were induced ~sixfold by both rhCG and ATR treatment, whereas PRO, SIM, and TBA had negligible effects. Only TBA repressed Cyp19a1 (fivefold). None of the treatments altered Cyp11a1 expression.
The temporal effects of ATR, PRO, SIM, and TBA on steroidogenic mRNA levels were also examined (Fig. 5) . Despite some differences in triazines-versus rhCG-elicited concentration-response profiles at 24 h, time-dependent ATR-, PRO-, and TBA-elicited steroidogenic gene expression profiles were comparable to rhCG albeit with differing efficacies. In general, Cyp11a1 and Cyp19a1 were unaffected by treatment, whereas Star, Hsd3b6, Hsd17b3, and Cyp17a1 were induced by rhCG and triazines, in agreement with the 24-h dose-response profiles. For example, Star was induced 2-to 4-fold by ATR, PRO, SIM, and TBA and 10-fold by rhCG with maximum expression achieved at 8-12 h. Similarly Cyp17a1 also showed peak induction at ~8 h with repression evident by 24-48 h for both rhCG and ATR. Furthermore, Srd5a1 exhibited divergent regulation with rhCG inducing expression fivefold from 8 to 24 h, whereas ATR, PRO, and TBA elicited > 80% repression from 24 to 48 h. Overall, SIM elicited negligible effects on the expression of the steroidogenic genes examined.
Temporal Whole-Genome Evaluation of Atrazine-Mediated Differential Gene Expression
Due to the similarities among the triazines and chlorometabolites, only ATR was investigated for genomewide differential gene expression as it had greater efficacy. Agilent microarrays contain ~41,000 features, representing 21,308 unique genes, with 797 differentially expressed (|fold change| > 1.5 and P1(t) > 0.999) by 300 μM ATR (Fig. 6A) . Differential gene expression increased over the course of the study with 23 genes at 1 h, 18 at 2 h, 117 at 4 h, 134 at 8 h, 284 at 12 h, 377 at 24 h, and 493 at 48 h (Fig. 6B) . Star induction measured by microarray was validated by QRTPCR, demonstrating comparable time-dependent profiles and levels of induction from 4 to 48 h (Fig. 6C) . K-means analysis of the 797 differentially expressed genes identified three distinct clusters with 317 induced, 362 repressed, and 118 exhibiting induction from ~4 to 24 h that tapered by 48 h (Fig. 7) . The Ingenuity transcription factor tool predicted enrichment of androgen receptor (AR) activity (24 and 48 h, p value 7.59e−03) based on 19 differentially expressed AR target genes at 24 and 48 h, of which 10 were repressed and 9 exhibited induction. The AR target genes contributing to the prediction of AR signaling activation were all differentially expressed at later time points, coinciding with increasing testosterone levels detected at 24 and 48 h (Fig. 3) . However, AR mRNA expression levels were not altered by ATR, suggesting that the activation of AR signaling was a result of androgen binding rather than increased expression.
Functional annotation was conducted using DAVID and IPA to identify enriched GO terms and overrepresented functions, respectively (Table 1) . Enriched GO terms were associated with hormone metabolism and regulation (including steroidogenic gene expression evaluated by QRTPCR) as well as cholesterol   FIG. 2 . Dose-response effects of triazines and major chlorometabolites on secreted P and T levels at 24 h. Dose-dependent induction of P (A) and T (B) levels measured in the media by EIA 24 h posttreatment using DMSO as the vehicle control (open bars), 0.1-100 ng/ml rhCG or 1-600 μM PRO, ATR, SIM, TBA, DEA, DACT, or DIA (solid bars). All triazines and chlorometabolites elicited dose-dependent induction of P and T levels albeit with lower efficacy compared with rhCG. Data are plotted as means ± standard error and were analyzed using ANOVA followed by Dunnett's post hoc test, n = 3, *p < 0.05 (See Supplementary table 3 for concentration values). biosynthesis and metabolism. Examples included cholesterol de novo biosynthesis-related genes such as Hmcgr, Hmgcs1, Lss, Sqle, and Cyp51 (all showing 1.5-to 2-fold induction at 8-12 h), cholesterol transport and uptake (Star up to 3-fold from 4 to 48 h and Ldlr 2-fold at 8 and 12 h), and metabolism into steroids (as demonstrated by QRTPCR of steroidogenic enzyme expression, Fig. 5 ). IPA transcription factor analysis also predicted the activation of Srebf1 (Table 2) and Srebf2 (p value 1.70e-05), which regulate gene expression associated with sterol homeostasis. The predicted activation of Srebf1 and Srebf2 was consistent with the intermediate upregulation of their target genes as identified in K-means clustering. In addition, Lhcgr the cell surface receptor for LH/rhCG was upregulated 1.6-fold at 24 h.
IPA also identified functions associated with reproduction as overrepresented. This included the induction of Rad18, Insl6, and Prnp (1.5-fold at 48 h) required for spermatogenesis, as well as the repression of Srd5a1 and Srd5a3 (2-fold at 48 h) required for male reproductive development. Tissue development and morphology were also overrepresented and included several actin regulatory proteins genes such as Avil (induced twofold at 48 h), Fmn1 (induced ~twofold at 8-12 h), and Cald1 (downregulated ~twofold at 8-48 h). The predicted activation of Creb1 and Atf4 (Table 2) suggests cAMP-mediated gene expression and included the induction of Vegfa, Gadd45a, and Bcat1 consistent with changes in cell morphology and growth. Induction of the phosphodiesterase (PDE) genes Pde4b (up 1.8-fold at 12-48 h), Pde4dip (up 1.6-fold at 24 h), and Pde10a (up to 3-fold at 4-48 h) is also indicative of cAMP signaling. The predicted activation of CCAAT/enhancer-binding proteins (Cebp), Cebpa (p value 4.38e−05), and Cebpb (Table 2) , as well as ATRmediated differential expression of Cebpd (repressed 1.5-fold at 12 h) and Cebpg (upregulated 1.5-fold at 24 h) further suggest ATR-mediated changes in cellular growth and differentiation. Interestingly, BLTK1 cells exhibited morphological changes (e.g., contracted cell bodies, increased pseudopod length) in   FIG. 3 . Time-dependent effects of triazines and chlorometabolites on P and T levels. BLTK1 cells were treated with 3 ng/ml rhCG or 300 μM of ATR, PRO, SIM, TBA (A and B), or chlorometabolite (i.e., DEA, DACT, or DIA) (C and D) and evaluated for effects on P and T levels relative to time-matched DMSO (vehicle control). P (A and C) and T (B and D) levels were measured at each time point by EIA. P levels in media increased within 2 h of treatment followed by a gradual decrease over time. In contrast, T levels exhibited a concomitant time-dependent increase following treatment. Data were plotted as mean ± standard error. Statistical significance was determined using ANOVA followed by Tukey's post hoc test, n = 3 (See Supplementary table 4 for concentration values and statistics).
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response to rhCG at 24 h (Fig. 8). MTT (Supplementary fig.  S1 ) and trypan blue staining (data not shown) indicated no significant rhCG-or ATR-elicited cytotoxicity with no effects on cell growth or doubling time over the 48-h time course based on cell counting (data not shown).
DISCuSSION
The endocrine-disruptive effects of triazines have been extensively studied in vivo (Cooper et al., 2007; Fraites et al., 2009; Hayes et al., 2010; Laws et al., 2003; Pogrmic et al., FIG. 4 . Dose-response evaluation of triazines-and rhCG-mediated gene expression. The dose-dependent effects of rhCG (black striped bars), PRO (medium grey bars), ATR (white bars), SIM (light grey bars), or TBA (black solid bars) on steroidogenic enzyme gene expression examined 24 h posttreatment using QRTPCR. Data are plotted as mean ± standard error of three independent replicates, *p < 0.05 versus DMSO controls.
TRIAZINES ALTER STEROIDOGENESIS IN BLTK1 CELL
2009; Stoker et al., 2002 Stoker et al., , 2000 Zorrilla et al., 2010) ; however, their mechanism remains unresolved. ATR, SIM, PRO, TBA, and DACT all induce mammary gland tumors in female Sprague Dawley rats, which was the common mode of action used to define them as a CMG (Cooper et al., 2007; USEPA, 2002) . The CMG also includes the chlorometabolites DEA, DIA, and DACT, which are found in drinking water and food and elicit comparable HPG axis disruption (Laws et al., 2003 USEPA, 2002) . At the time, only ATR, SIM, and PRO were deemed to have uses that result in exposure to the general public, thus excluding TBA from the CMG. ATR and SIM exposure was of greatest risk due to widespread use and persistence in ground and surface water (Gilliom et al., 2006) . Estimations of human ATR exposure based on urine levels of turf applicators are ~2 μM ATR equivalents (including metabolites), whereas acute exposure is approximately half this amount ( Barr   FIG. 5 . Time-dependent effects of triazines-and rhCG-mediated steroidogenic gene expression. Temporal gene expression profiling of steroidogenic enzymes in response to 3 ng/ml rhCG (black striped bars) or 300μM of PRO (medium grey bars), ATR (white bars), SIM (light grey bars), or TBA (black solid bars), respectively, was examined by QRTPCR. Data are plotted as mean ± standard error of three independent replicates, *p < 0.05 versus time-matched DMSO controls.
162 FORGACS ET AL. et al., 2007) . ATR metabolite profiles in human urine consist of 50% DACT, 30% DEA, and 5% DIA (Barr et al., 2007) . Rodent studies suggest similar ATR metabolism, primarily by CYP1A1/2 (Hanioka et al., 1999; Ross et al., 2009) . Maximum plasma levels in mice are achieved within 1 h, with maximum DACT plasma concentrations within 2 h postdose (Ross et al., 2009) . Chlorometabolite concentrations of ~2 μM are reported in serum with less than 1 μM of parent compound following administration of 200 mg/kg ATR or an equimolar SIM or PRO dose in male Wistar rats . Although these human and rodent urine and serum levels encompass the concentrations used in our concentration-response studies, the effects on steroidogenesis appear to occur at triazine levels not encountered by humans, even in occupational environments.
Responses in BLTK1 cells are consistent with in vivo studies indicating that ATR, PRO, DEA, DIA, and DACT induce dose-dependent increases in serum P levels in male Wistar rats within 15 min to 3 h with no significant induction in response to SIM . SIM treatment for 41 days delayed vaginal opening and the onset of puberty in female rats (Zorrilla et al., 2010) , suggesting more modest disruption of steroidogenesis compared with other triazines and chlorometabolites in agreement with its effects in BLTK1 cells. ATR and DIA were reported to be equally efficacious on eliciting changes in plasma P levels in male Wistar rats , consistent with their equipotent induction of P and T levels in BLTK1 cells. Additionally, DACT was described to be the least efficacious in male Wistar rats , also consistent T induction in the current study where it had no effects at concentrations < 600 μM. In addition, the CMG categorization of ATR, PRO, SIM, DEA, DIA, and DACT is in agreement with their P and T induction effects in BLTK1 cells as demonstrated by their similar EC 50 values (Laws et al., 2003) . Furthermore, TBA elicits comparable effects including P and T induction and differential steroidogenic gene expression. Moreover, the effects of all triazines and their cholormetabolites, including TBA, are similar to effects reported in rat primary Leydig cells at doses as low as 20 μM ATR (Pogrmic-Majkic et al., 2010) . Despite differences in the differential expression of specific steroidogenic genes, the effects on P and T levels were comparable across all treatments, suggesting ATR, PRO, SIM, and TBA as well as their major chlorometabolites alter the regulation of steroidogenesis using a common mode of action.
Activation of Leydig cell steroidogenesis exhibits (1) an acute phase initiated by gonadotropin binding to LHCGR and 
induction of intracellular cAMP and PKA signaling events and (2) a longer term effect involving differential gene expression and increased steroidogenic enzyme expression that affects the steroidogenic maintenance (Chen et al., 2007) . Although the acute phase induces immediate T levels, sustained production requires both phases. ATR alters basal T levels in BLTK1 cells and alters Star, Hsd3b, Cyp17a1, and Hsd17b expression in rat primary Leydig cells (Pogrmic et al., 2009) . The current study extends the effects on P and T levels to other triazines and their major chlorometabolites to include time-and dose-dependent effects on the long-term phase of steroidogenesis. Most ATR-elicited differential gene expression occurred after 12 h, suggesting effects on long-term steroidogenesis. For example, although Star and Cyp17a1 showed maximum induction at ~8 h, repression at later time points (24-48 h) is consistent with the feedback inhibition exerted by androgens mediated by the AR (Hales et al., 1987; Houk et al., 2004) . These genes contributed to the prediction of AR activation at later time points (24-48 h), most likely due to increasing T levels at these time points. In addition, the induction of several cholesterol biosynthetic genes and predicted activation of Srebf1 and Srebf2 are consistent with steroid biosynthesis and longer term maintenance of steroidogenesis.
The early induction of Star also coincides with immediate increases in P and T levels. Star mediates the rate-limiting transport of cholesterol to the inner mitochondrial membrane required for steroidogenesis and is one of the few genes with significant induction at earlier time points. Star expression is largely cAMP mediated, with cAMP levels regulated not only by production but also by phosphodiesterase (PDE) turnover (Tsai and Beavo, 2011) . ATR is reported to inhibit PDE4 in rat Leydig and anterior pituitary cells (Kucka et al., 2012) , human recombinant PDE4A1 (USEPA, 2012b), and cAMP-specific PDEs in swine (Roberge et al., 2004 (Roberge et al., , 2006 . Biologically Multiplexed Activity Profiling (BioMAP; a primary, human, cell-based assays covering a diverse array of regulatory networks with a broad range of target mechanisms relevant to human toxicity) also suggests that ATR, SIM, and PRO increase cAMP levels, consistent with PDE inhibition (Houck et al., 2009) . These data suggest that the late induction of Pde10a, Pde4b, and Pde4dip in BLTK1 cells at 48 h may be a compensatory response to PDE inhibition that warrants further investigation. Collectively, the current study demonstrates the effects of the CMG triazines, as well as TBA, and their primary chlorometabolites on steroidogenesis in BLTK1 Leydig cells. Our data suggest that altered gene expression may underlie the long-term steroidogenic effects of triazines and their chlorometabolites although additional studies are needed to FIG. 7. K-means clustering of atrazine-elicited temporal whole-genome gene expression. ATR (300 μM) elicited the differential expression (|fold change| > 1.5 and P1(t) > 0.999) of 797 genes. K-means clustering using a Pearson correlation distance metric identified three distinctive profiles: increasing downregulation (362 genes), increasing upregulation (317 genes), and intermediated upregulation (118 genes). Light grey lines illustrate the profile of each gene within the cluster, whereas the dark grey line illustrates the average trend for the group. elucidate their acute effects on P and T levels. Although our results are consistent with other reports of triazines inducing P and/or T levels Laws et al., 2009; PogrmicMajkic et al., 2010; Tinfo et al., 2011) , other in vivo studies show triazines antagonize serum T levels (Friedmann, 2002; Jin et al., 2013; Trentacoste et al., 2001; Victor-Costa et al., 2010) . Preliminary studies suggest that triazines antagonize rhCG-stimulated steroidogenesis (Forgacs et al., 2012) , and ongoing cotreatment studies with triazine and rhCG are examining potential triazine targets that underlie the disruption of steroidogenesis in BLTK1 Leydig cells. Note. *Transcription factors are predicted to be activated or deactivated based on the differential expression of known target genes. Time point of activation/ deactivation (in brackets) and the number of genes contributing to prediction are provided.
FIG. 8.
BLTK1 cell morphology. Cells were photographed using a phase/contrast microscope at 10× magnification 24 and 48 h after treatment with DMSO, 3 ng/ml rhCG, or 300 µM ATR. 
